Rockwell Medical (RMTI) Interest & Investment Income (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Interest & Investment Income came in at $37000.0 in Q1 2026, down 43.94% YoY from $66000.0 in Q1 2025, and down 15.91% on a QoQ basis from $44000.0 in Q4 2025.
Rockwell Medical (RMTI) Interest & Investment Income (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Interest & Investment Income data on file, last reported at $37000.0 in Q1 2026.
- Quarterly Interest & Investment Income fell 43.94% year-over-year to $37000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $205000.0 (up 52.99% YoY) and the FY2025 annual result came in at $234000.0, up 154.35% from the prior year.
- Interest & Investment Income retreated to $37000.0 in Q1 2026, from $44000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $69000.0 in Q2 2025 to a low of -$6000.0 in Q3 2022.
- A 5-year average of $40733.3 and a median of $43000.0 in 2022 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income surged 1033.33% — and 2024, when it slumped 81.63%.
- Tracing RMTI's Interest & Investment Income over 5 years: stood at $43000.0 in 2022, then slipped by 2.33% to $42000.0 in 2023, then plunged by 30.95% to $29000.0 in 2024, then surged by 51.72% to $44000.0 in 2025, then dropped by 15.91% to $37000.0 in 2026.
- The last three Interest & Investment Income figures came in at $37000.0 (Q1 2026), $44000.0 (Q4 2025), and $55000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Rockwell Medical | 29.69 Mn | 4.89 Mn | 3.24 Mn | 40,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40,000.00 |
| Mar 31, 2026 | 37,000.00 |
| Dec 31, 2025 | 44,000.00 |
| Sep 30, 2025 | 55,000.00 |
| Jun 30, 2025 | 69,000.00 |
| Mar 31, 2025 | 66,000.00 |
| Dec 31, 2024 | 29,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Dec 31, 2023 | 42,000.00 |
| Sep 30, 2023 | 56,000.00 |
| Jun 30, 2023 | 49,000.00 |
| Mar 31, 2023 | 64,000.00 |
| Dec 31, 2022 | 43,000.00 |
| Sep 30, 2022 | -6,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Jun 30, 2021 | 7,000.00 |
| Mar 31, 2021 | 11,000.00 |
| Dec 31, 2020 | -1,000.00 |